VILDAVAS-50 contains Vildagliptin 50 mg, a DPP-4 inhibitor used in the management of Type 2 Diabetes Mellitus. It helps improve blood glucose control by enhancing the body's natural insulin response and reducing excessive glucagon release.
VILDAVAS-50 contains Vildagliptin 50 mg, a DPP-4 inhibitor used in the management of Type 2 Diabetes Mellitus. It helps improve blood glucose control by enhancing the body's natural insulin response and reducing excessive glucagon release.